Peter Antturi joined Gene Bio Medical’s board in 2022 and brings management leadership, mentoring, and strong corporate governance capacity to the company.

Peter holds various significant roles in some public companies. He joined the board of Teekay Corporation in June 2019 and brings over 30 years of financial and operational experience in the shipping industry to this role. He also joined the board of Teekay Tankers Ltd. in June 2021.

Additionally, Mr. Antturi serves as an executive officer and director of Teekay Corporation’s largest shareholder,

Resolute Investments, Ltd. (Resolute), as well as other subsidiaries and affiliates of Kattegat Limited, a parent company of Resolute. Mr. Antturi previously worked with Teekay from 1991 through 2005, serving as President of Teekay’s shuttle tanker division, as Senior Vice President, Chief Financial Officer and Controller and in other finance and accounting positions. Prior to joining Teekay, Mr. Antturi held various accounting and finance roles in the shipping industry since 1985.